标题/作者	年份
Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: from antibodies to small molecules J Yang, L Hu Medicinal research reviews 39 (1), 265-301	2019
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements RA Luchtel, S Dasari, N Oishi, MB Pedersen, G Hu, KL Rech, ... Blood, The Journal of the American Society of Hematology 132 (13), 1386-1398	2018
Molecular pathogenic pathways in extranodal NK/T cell lymphoma S de Mel, SSS Hue, AD Jeyasekharan, WJ Chng, SB Ng Journal of hematology & oncology 12, 1-18	2019
The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface M Meggyes, E Miko, B Szigeti, N Farkas, L Szereday BMC pregnancy and childbirth 19 (1), 1-12	2019
Correlation between PD-L2 expression and clinical outcome in solid cancer patients: a meta-analysis H Yang, X Zhou, L Sun, Y Mao Frontiers in oncology 9, 47	2019
PD-1/PD-L1 pathway and its blockade in patients with classic Hodgkin lymphoma and non-Hodgkin large-cell lymphomas W Xie, LJ Medeiros, S Li, CC Yin, JD Khoury, J Xu Current Hematologic Malignancy Reports 15, 372-381	2020
Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma S Hartmann, DA Eichenauer Pathology 52 (1), 142-153	2020
Novel immunotherapy options for extranodal NK/T-cell lymphoma B Hu, Y Oki Frontiers in oncology 8, 139	2018
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma J Shen, S Li, LJ Medeiros, P Lin, SA Wang, G Tang, CC Yin, MJ You, ... Modern Pathology 33 (3), 324-333	2020
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up H Zhou, ZY Xu-Monette, L Xiao, P Strati, FB Hagemeister, Y He, H Chen, ... Blood cancer journal 10 (5), 49	2020
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma M Kawashima, J Carreras, H Higuchi, R Kotaki, T Hoshina, K Okuyama, ... Leukemia 34 (9), 2405-2417	2020
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: An open-label phase 2 study (Gxplore-002) Y Shi, J Wu, Z Wang, L Zhang, Z Wang, M Zhang, H Cen, Z Peng, Y Li, ... Journal of hematology & oncology 14 (1), 1-13	2021
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas V Tabanelli, C Corsini, S Fiori, C Agostinelli, A Calleri, S Orecchioni, ... Human Pathology 90, 60-69	2019
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, PD‐L1 copy number alterations, and outcome L Veloza, C Teixido, N Castrejon, F Climent, A Carrió, M Marginet, ... Histopathology 75 (6), 799-812	2019
Immune checkpoint inhibition in classical Hodgkin lymphoma: from early achievements towards new perspectives D De Goycoechea, G Stalder, F Martins, MA Duchosal Journal of oncology 2019	2019
Atlas of PD-L1 for pathologists: indications, scores, diagnostic platforms and reporting systems S Marletta, N Fusco, E Munari, C Luchini, A Cimadamore, M Brunelli, ... Journal of Personalized Medicine 12 (7), 1073	2022
Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma M Tagawa, C Kurashima, S Takagi, N Maekawa, S Konnai, G Shimbo, ... PLoS One 13 (7), e0201222	2018
Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile M Weber, F Wehrhan, C Baran, A Agaimy, M Büttner‐Herold, M Kesting, ... Cancer medicine 8 (3), 1124-1134	2019
Immune evasion‐related extranodal large B‐cell lymphoma: a report of six patients with neoplastic PD‐L1‐positive extranodal diffuse large B‐cell lymphoma Y Suzuki, A Sakakibara, K Shimada, S Shimada, E Ishikawa, S Nakamura, ... Pathology International 69 (1), 13-20	2019
A study of PD‐L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features GK Gupta, ES Jaffe, S Pittaluga Histopathology 75 (2), 282-286	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。